Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Cash & Current Investments: 2022-2025

Historic Cash & Current Investments for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $246.2 million.

  • Centessa Pharmaceuticals' Cash & Current Investments fell 52.51% to $246.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 2.80%. This contributed to the annual value of $482.2 million for FY2024, which is 87.95% up from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Cash & Current Investments stood at $246.2 million, which was down 1.80% from $250.7 million recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Cash & Current Investments peaked at $544.5 million during Q1 2022, and registered a low of $230.2 million during Q1 2024.
  • Its 3-year average for Cash & Current Investments is $317.7 million, with a median of $284.5 million in 2025.
  • Per our database at Business Quant, Centessa Pharmaceuticals' Cash & Current Investments spiked by 87.95% in 2024 and then slumped by 52.51% in 2025.
  • Quarterly analysis of 4 years shows Centessa Pharmaceuticals' Cash & Current Investments stood at $393.6 million in 2022, then plummeted by 34.83% to $256.5 million in 2023, then soared by 87.95% to $482.2 million in 2024, then crashed by 52.51% to $246.2 million in 2025.
  • Its Cash & Current Investments was $246.2 million in Q3 2025, compared to $250.7 million in Q2 2025 and $284.5 million in Q1 2025.